83 related items for PubMed ID: 1855324
1. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
Woo KT, Lee GS.
Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
[No Abstract] [Full Text] [Related]
2. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[Abstract] [Full Text] [Related]
3. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
Brodsky SV, Rovin BH, Hebert LA.
Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
[No Abstract] [Full Text] [Related]
4. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[Abstract] [Full Text] [Related]
5. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
Woo KT, Chiang GS, Lim CH.
Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
[No Abstract] [Full Text] [Related]
6. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
Woo KT, Lee GS, Pall AA.
Kidney Int; 2000 Jan; 57(1):348-9. PubMed ID: 10712116
[No Abstract] [Full Text] [Related]
7. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH.
Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
[Abstract] [Full Text] [Related]
8. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS.
Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
[Abstract] [Full Text] [Related]
9. A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Moriya T, Nakazawa K, Itoh N, Shigematsu H, Higuchi M, Miyasaka M, Oguchi H.
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):423-30. PubMed ID: 1635288
[Abstract] [Full Text] [Related]
10. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
Shearman JD, Yin ZG, Aarons I, Smith PS, Woodroffe AJ, Clarkson AR.
Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
[Abstract] [Full Text] [Related]
11. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
Lee GS, Woo KT, Lim CH.
Clin Nephrol; 1989 May; 31(5):276. PubMed ID: 2661066
[No Abstract] [Full Text] [Related]
12. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H, Japanese Pediatric IgA Nephropathy Treatment Study Group.
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[Abstract] [Full Text] [Related]
13. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M.
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[Abstract] [Full Text] [Related]
14. Combined therapy in children and adolescents with IgA nephropathy.
Murakami K, Yoshioka K, Akano N, Takemura T, Okada M, Aya N, Hino S, Miyazato H, Yagi K, Maki S.
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
[Abstract] [Full Text] [Related]
15. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
Yoshikawa N, Ito H.
Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
[No Abstract] [Full Text] [Related]
16. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
[Abstract] [Full Text] [Related]
17. IgA nephritis in Singapore: clinical, prognostic indices, and treatment.
Woo KT, Chiang GS, Lau YK, Lim CH.
Semin Nephrol; 1987 Dec; 7(4):379-81. PubMed ID: 3445021
[No Abstract] [Full Text] [Related]
18. Clinical effect of dipyridamole in patients with IgA nephropathy.
Yagame M, Tomino Y, Miura M, Suga T, Endoh M, Nomoto Y, Sakai H.
Tokai J Exp Clin Med; 1986 Nov; 11(5):329-33. PubMed ID: 2960035
[Abstract] [Full Text] [Related]
19. Rapidly progressive glomerulonephritis: treatment with combined immunosuppression and anticoagulation with arvin.
Segasothy M, Kong CT, Morad Z, Suleiman AB, Phang KS.
Singapore Med J; 1986 Oct; 27(5):422-7. PubMed ID: 3823948
[No Abstract] [Full Text] [Related]
20. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.
Takemura T, Okada M, Yagi K, Kuwajima H, Yanagida H.
Pediatr Nephrol; 2002 Oct; 17(10):863-6. PubMed ID: 12376818
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
